4//SEC Filing
ORLOFF JOHN J 4
Accession 0000899866-21-000062
CIK 0000899866other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 4:29 PM ET
Size
5.2 KB
Accession
0000899866-21-000062
Insider Transaction Report
Form 4
ORLOFF JOHN J
EVP, Research & Development
Transactions
- Disposition to Issuer
Common Stock, par value $.0001 per share
2021-07-21−146,511→ 0 total
Footnotes (1)
- [F1]Represents shares of Alexion common stock disposed in connection with the Agreement and Plan of Merger (the "Merger Agreement") dated as of December 12, 2020, by and among Alexion and AstraZeneca PLC. In accordance with the Merger Agreement, upon the First Effective Time (as defined in the Merger Agreement), each share of Alexion common stock was converted into the right to receive (i) 2.1423 American Depositary Shares (ADSs) of AstraZeneca PLC and (ii) $60.00 in cash (the "Merger Consideration").
Documents
Issuer
ALEXION PHARMACEUTICALS, INC.
CIK 0000899866
Entity typeother
Related Parties
1- filerCIK 0001643941
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 4:29 PM ET
- Size
- 5.2 KB